Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Caroline Leuenberger (Zurich, Switzerland), Caroline Leuenberger, Claudio Schuoler, Célia Mignan, Thomas Rechsteiner, Malcolm Kohler, Lars Huber, Matthias Brock. microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease. Eur Respir J 2015; 46: Suppl. 59, 2931

Member's Comments

No comment yet.

Related content which might interest you: Dysregulation of serum miRNA in chronic obstructive pulmonary disease Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015 Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study Source: Eur Respir J 2010; 36: 89-95 Year: 2010 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Mucin 1 downregulation associates with corticoid resistance in chronic obstructive pulmonary disease and chronic rhinosinusitis with nasal polyps Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Case control study of chronic obstructive pulmonary disease and its progression Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 Targeting the mTOR signaling pathway to inhibit lung cell senescence in chronic obstructive pulmonary disease (COPD) Source: ERS Lung Science Conference 2017 Year: 2017 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 PF-03715455: An inhaled p38 inhibitor for the treatment of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013 Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2009 - COPD: basic science and clinical studies Year: 2009 The role of histone deacetylase 2 (HDAC2) and glucocorticoid receptor (GR) isoforms α, β in patients with asthma–COPD overlap syndrome (ACOS) Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD markers Year: 2014 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 Epigenetic-like regulation of signalling proteins in chronic obstructive pulmonary disease Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019